Overcoming the drug resistance in breast cancer cells by rational design of efficient glutathione S-transferase inhibitors.

A new type of competitive human GST inhibitors has been developed via the bioisostere and structure activity profile strategies; we report their discovery, preparation, inhibitory activity, and synergetic effect in combination with chemotherapy drugs against breast cancer cells.